CA
GEHC icon

Cullinan Associates’s GE HealthCare GEHC Stock Holding History

Cullinan Associates’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,687
Closed -$242K – 227
2024
Q3 		$242K Sell
2,687
-833
-24% -$69.9K 0.01% 218
2024
Q2 		$274K Sell
3,520
-171
-5% -$13.9K 0.02% 216
2024
Q1 		$336K Sell
3,691
-21
-0.6% -$1.75K 0.02% 214
2023
Q4 		$287K Hold
3,712
– – 0.02% 210
2023
Q3 		$253K Hold
3,712
– – 0.01% 229
2023
Q2 		$302K Sell
3,712
-185
-5% -$14.8K 0.02% 225
2023
Q1 		$320K Buy
+3,897
New +$278K 0.02% 217

Other funds holding GEHC

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cullinan Associates's GEHC Position: Q4 2024 in Review

Cullinan Associates sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 2,687 shares — an estimated $242K sold.

Cullinan Associates first reported a position in GEHC in Q1 2023 and held it in 7 quarters. The position peaked at $336K in Q1 2024. 1,329 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

  • Cullinan Associates reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
  • Cullinan Associates sold 2,687 GE HealthCare shares in Q4 2024, an estimated $242K.
  • Cullinan Associates first reported a position in GE HealthCare in Q1 2023 and held it in 7 quarters.
  • Cullinan Associates's GE HealthCare position peaked at $336K in Q1 2024.
  • 1,329 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on Cullinan Associates's 13F filing for Q4 2024, filed 24 Jan 2025.